(Q40246451)

18 September 2017

title

Cannabinoid receptors in human astroglial tumors (English)

1 reference

18 September 2017

0 references

0 references

0 references

1 reference

5

1 reference

18 September 2017

Janka Held-Feindt

1

1 reference

18 September 2017

Lutz Dörner

series ordinal

2

1 reference

18 September 2017

Gülcan Sahan

series ordinal

3

1 reference

18 September 2017

H Maximilian Mehdorn

series ordinal

4

1 reference

18 September 2017

language of work or name

English

0 references

publication date

1 August 2006

1 reference

Journal of Neurochemistry

18 September 2017

published in

1 reference

18 September 2017

volume

98

1 reference

18 September 2017

issue

3

1 reference

18 September 2017

page(s)

886-893

1 reference

Role of microglia in glioma biology

18 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2006.03911.X

Cannabinoids inhibit the vascular endothelial growth factor pathway in gliomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2006.03911.X

Cultured rat microglial cells synthesize the endocannabinoid 2-arachidonylglycerol, which increases proliferation via a CB2 receptor-dependent mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2006.03911.X

The synthetic cannabinoid R(+)WIN 55,212-2 inhibits the interleukin-1 signaling pathway in human astrocytes in a cannabinoid receptor-independent manner

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2006.03911.X

Receptors and effects of the inhibitory neuropeptide somatostatin in microglial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2006.03911.X

Anti-tumoral action of cannabinoids: involvement of sustained ceramide accumulation and extracellular signal-regulated kinase activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2006.03911.X

Cannabinoids: potential anticancer agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2006.03911.X

Cannabinoids induce cancer cell proliferation via tumor necrosis factor alpha-converting enzyme (TACE/ADAM17)-mediated transactivation of the epidermal growth factor receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2006.03911.X

International Union of Pharmacology. XXVII. Classification of cannabinoid receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2006.03911.X

Enhanced expression and shedding of the transmembrane chemokine CXCL16 by reactive astrocytes and glioma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2006.03911.X

Antitumor effects of cannabidiol, a nonpsychoactive cannabinoid, on human glioma cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2006.03911.X

Somatostatin inhibits the production of vascular endothelial growth factor in human glioma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2006.03911.X

Cannabinoid CB2 receptors are expressed by perivascular microglial cells in the human brain: an immunohistochemical study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2006.03911.X

Expression of pleiotrophin, an embryonic growth and differentiation factor, in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2006.03911.X

Antitumor effects of ajulemic acid (CT3), a synthetic non-psychoactive cannabinoid

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2006.03911.X

Delta9-tetrahydrocannabinol induces apoptosis in C6 glioma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2006.03911.X

Cannabinoid signaling in glial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2006.03911.X

Cannabidiol inhibits human glioma cell migration through a cannabinoid receptor-independent mechanism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2006.03911.X

Hypothesis: cannabinoid therapy for the treatment of gliomas?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2006.03911.X

10.1111/J.1471-4159.2006.03911.X

21 January 2018

Identifiers

DOI

1 reference

18 September 2017

1 reference